Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 163
Selected: 0
NCT IDTitle
NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT00963027Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
NCT01260454The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
NCT03888365Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT00147199Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
NCT05203510A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
NCT02583789Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT04090866Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT01557660Inhaled Treprostinil for PAH: Open-label Extension
NCT02633293An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT03055221TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)
NCT00067041Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
NCT05245006PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
NCT06580444Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT00325403FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT03481725Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study
NCT00373360Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT00494533Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
NCT06964009DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT02279160Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
NCT05421897Rapid Administration Pilot for Infusing Dinutuximab
NCT01750684AC105 in Patients With Acute Traumatic Spinal Cord Injury
NCT02318186Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
NCT03833323Implantable System for Remodulin Post-Approval Study
NCT04246281The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain
NCT01027949An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT04677829Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT03332667MIBG With Dinutuximab +/- Vorinostat
NCT00911248PTC299 for Treatment of Neurofibromatosis Type 2
NCT03043651Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
NCT03047369The Myelin Disorders Biorepository Project
NCT01393795Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
NCT02882126An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
NCT03016468Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
NCT07037836Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia